NHS Plymouth Introduces Tunstall's Telehealth Solutions

TunstallNHS Plymouth has partnered with Tunstall to implement a telehealth programme that will support the management of long-term conditions (LTCs) for patients in Plymouth.

The telehealth initiative will give patients greater control over their condition, allowing them to monitor it from home with the reassurance that professional support is available if required. This will significantly reduce the hospital admission rate for patients living with LTCs, giving them greater freedom and the opportunity to live more independent lives.

NHS Plymouth's decision to undertake a telehealth programme came about following the need to drive efficiency within its services by tackling the rising costs of treating long-term conditions whilst at the same time improving patients' quality of life. The programme will initially be available to 100 patients living chronic obstructive pulmonary disease (COPD), and/or chronic heart failure (CHF).

Jane Griffin, Lead Commissioning Manager of Long Term Conditions for NHS Plymouth, said: "We were aware of the possible benefits of telehealth from a number of schemes carried out by other PCTs, and so the decision was made to implement a small-scale programme to see if it could be as beneficial for us and our patients' needs. This is an opportunity for NHS Plymouth to use technological advances for the benefit of our patients. Our aim is to support patients to self care and give them greater independence and we are confident that the telehealth programme will enable this to happen."

Simon Arnold, Tunstall's Managing Director said: "Plymouth's new telehealth programme will deliver efficiency gains by helping the NHS to manage long-term conditions more cost-effectively, reducing unplanned admissions to emergency and secondary care and supporting patients in the home environment. Patients will be able to actively manage their own conditions, whilst being able to live more independently without the constraints of frequent and often lengthy hospital admissions."

Related news articles:

About Tunstall
Tunstall Healthcare Group is the market leading provider of telehealthcare solutions, with over 2.5 million users globally. Tunstall’s solutions support older people and those with long-term needs, to live independently, by effectively managing their health and well-being. Tunstall provides technology, expertise and advice to millions of people enabling them to lead independent more fulfilling lives.

Most Popular Now

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...